INOVA is proud of our scientific prowess which is made evident by our numerous publications in peer reviewed scientfic journals. Please feel free to review the references below which are arranged by disease state.
Liver | Antiphospholipid Syndrome | Connective Tissue | Gastrointestinal | RA
Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol. 34:1528-34, 2007
http://www.jrheum.com/abstracts/abstracts07/1528.html
Burlingame RW and Peebles C. Detection of Autoantibodies. Autoantibodies and Autoimmunity. Ed. KM Pollard, Wiley-VCH Verlag GmbH and Co., Weinheim, Germany: 159-88, 2006.
Chan EKL, Burlingame RW, Fritzler MJ. Detection of Autoantibodies using immobilized natural and recombinant autoantigens. Systemic Autoimmune Diseases, eds. ASM Press, Washington, DC: 2006.
Gomez-Puerta JA, Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) antibodies. Lupus 15: 408-11, 2006.
Williams RC Jr, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 32: 454-61, 2005.
Burlingame, RW. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (anti-chromatin) autoantibodies. Clinical and Applied Immunology Reviews 4 (2004) 351-366.
Martins, T. B., R. Burlingame, C.A. von Muhlen, T.D. Jaskowski, C.M. Litwin and H.R.Hill. Evaluation of multiPlexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 11: 1054-1059, 2004.
Burlingame, RW. The Clinical Utility Of AntiHistone Antibodies. Autoantibodies Reactive with Chromatin in Systemic Lupus Erythematosus and Drug-Induced Lupus. Clinics In Laboratory Medicine Vol 17. No 3. September 1997.
Czaja, A.J., Shums, Z, Binder WL, Lewis SJ, Nelson VJ, and Norman, GL. Frequency and Significance of antibodies to chromatin in autoimmune hepatitis type 1. Dig.Dis. Sci .2003, 48(8): 1658-1664.
Cervera, R., O. Vinas, M. Ramos-Casals, J. Font, M. Garcia-Carrasco, A. Siso, F. Ramirez, Y. Machuca, J. Vives, M. Ingelmo and R.W. Burlingame. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62: 431-434, 2003.
Burlingame, RW, Cervera,R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmunity Reviews 1 (2002) 321-328.
Burlingame, R.W. and R.L. Rubin. Enzyme-linked immunosorbent assays for diagnostically important antinuclear antibodies. Manual of Clinical Laboratory Immunology, 6th Edition, Eds. N.R. Rose, E.C. d Macario, J.D. Folds, H.C. Lane and R.M. Nakamura. ASM Press, Washington, DC: 951-960, 2002.
Burlingame, R.W. Contributing editor, immunology, biochemistry and genetics, The American Heritage Dictionary, 4rth Edition, Ed. J Pickett, Houghton-Mifflin Co., Boston, MA: 2000.
Burlingame,RW. The Clinical Utility Of AntiHistone Antibodies. Autoantibodies Reactive with Chromatin in Systemic Lupus Erythematosus and Drug-Induced Lupus. Clinics In Laboratory Medicine Vol 17. No 3. September 1997.
Burlingame, RW, Boey, ML, Starkebaum, G, and Rubin, RL. The Central Role of Chromatin in Autoimmune Responses to Histones and DNA in Systemic Lupus Erythematosus. The American Society for Clinical Investigation, Inc. Vol 94, July 1994,184-192.
Burlingame ,RW, and Rubin, RL. Drug-induced Anti-Histone Autoantibodies Display Two Patterns of Reactivity with Substructures of Chromatin. The American Society for Clinical Investigation Inc. Vol 88, August 1991,680-690.
Nakumura, RM, Binder, WL. Current Concepts and Diagnostic Evaluation of Autoimmune Disease. Archives of Pathology and Laboratory Medicine. September 1988 Vol 112: 869-877. Copyright 1988. American Medical Association.